Evidence map›Paper›PMID 28096895›Full record

ArticleComputational and mathematical methods in medicine2016

Towards the Design of a Patient-Specific Virtual Tumour.

Flavien Caraguel, Anne-Cécile Lesart, François Estève, Boudewijn van der Sanden, Angélique Stéphanou

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Hybrid modeling frameworks of tumor development and treatment.Wiley interdisciplinary reviews. Systems biology and medicine · 2020
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Flavien CaraguelClinatec, INSERM UA01, 38054 Grenoble, France.
Anne-Cécile LesartUniversité Grenoble Alpes, CNRS, TIMC-IMAG/DyCTIM2, 38041 Grenoble, France.
François EstèveUniversité Grenoble Alpes, EA 7442 RSRM, ID17-ESRF, 38000 Grenoble, France.
Boudewijn van der SandenClinatec, INSERM UA01, 38054 Grenoble, France.
Angélique StéphanouUniversité Grenoble Alpes, CNRS, TIMC-IMAG/DyCTIM2, 38041 Grenoble, France.ORCID 0000-0001-6399-0425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of a patient-specific virtual tumour is an important step towards Personalized Medicine. However this requires to capture the description of many key events of tumour development, including angiogenesis, matrix remodelling, hypoxia, and cell state heterogeneity that will all influence the tumour growth kinetics and degree of tumour invasiveness. To that end, an integrated hybrid and multiscale approach has been developed based on data acquired on a preclinical mouse model as a proof of concept. Fluorescence imaging is exploited to build case-specific virtual tumours. Numerical simulations show that the virtual tumour matches the characteristics and spatiotemporal evolution of its real counterpart. We achieved this by combining image analysis and physiological modelling to accurately described the evolution of different tumour cases over a month. The development of such models is essential since a dedicated virtual tumour would be the perfect tool to identify the optimum therapeutic strategies that would make Personalized Medicine truly reachable and achievable.

Indexed as

Neovascularization, PathologicAnimalsCell CycleCell DivisionCell Line, TumorCell ProliferationComputer SimulationDisease Models, AnimalEarExtracellular MatrixFemaleGreen Fluorescent ProteinsHumansImage Processing, Computer-AssistedIntercellular Signaling Peptides and ProteinsKineticsGreen Fluorescent ProteinsIntercellular Signaling Peptides and ProteinsOxygen

Identifiers

PMID28096895
PMCPMC5206790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.